We will use cookies and other information to optimize your experience. By continuing to browse, you consent to our use. For details, please read
Privacy Policy
×
EUSOL
choose
繁體中文
English
About Us
About Eusol
Company Organization
Corporate Responsibility
Chronology
Pipeline
Pipeline
News
Investor Area
Finance
Initial Public Offering
Corporate Governance
IR Contact
Agent for stock affairs
Charter
Stock Information
Stock Information
Material Message
Contact Us
Contact Us
Contact Info
Join Us
Disclaimer
Terms
Privacy
Home
News
News
10
AUGUST
2022
Co-Development of 505(b)2 new drugs with Pharmaceutical Partners
29
AUGUST
2018
Initial Public Offering
1
2
1
2
TOP
choose
繁體中文
English
About Us
About Eusol
Company Organization
Corporate Responsibility
Chronology
Pipeline
Pipeline
News
Investor Area
Finance
Initial Public Offering
Corporate Governance
IR Contact
Agent for stock affairs
Charter
Stock Information
Stock Information
Material Message
Contact Us
Contact Us
Contact Info
Join Us
Disclaimer
Terms
Privacy
